Michelle Monje
Stanford University and Lucile Packard Children's Hospital · Stanford University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michelle Monje as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:52 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04295759 · INCB7839 in Treating Children With Recurrent/Progressive High-Grade GliomasPediatric Brain Tumor Consortium · completed · Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma · study chair
- Ph1NCT04196413 · GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)Stanford University · recruiting · Glioma of Spinal Cord, Glioma of Brainstem · principal investigator
- Ph1NCT02717455 · Trial of Panobinostat in Children With Diffuse Intrinsic Pontine GliomaPediatric Brain Tumor Consortium · completed · Glioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Neuronal Regulation of Low-Grade GliomagenesisR01CA258384 · NCI · STANFORD UNIVERSITY · fiscal years 2022 to 2026 · $622,575 awarded in 2026Same name and institution; not confirmed by an ID
- Developing Safe and Effective GD2-CAR T Cell Therapy for Diffuse Midline GliomasR01CA263500 · NCI · STANFORD UNIVERSITY · fiscal years 2021 to 2025 · $660,052 awarded in 2025Grant number is on one of their registry trials
- Glioma Circuitry: Bridging Systems Neuroscience and CancerDP1NS111132 · NINDS · STANFORD UNIVERSITY · fiscal years 2018 to 2022 · $1,095,500 awarded in 2022Same name and institution; not confirmed by an ID
- Neuronal activity-regulated mechanisms of glioma growthR01NS092597 · NINDS · STANFORD UNIVERSITY · fiscal years 2016 to 2021 · $344,241 awarded in 2021Same name and institution; not confirmed by an ID
- Precursor cell-niche interactions and the genesis of brainstem gliomasK08NS070926 · NINDS · STANFORD UNIVERSITY · fiscal years 2010 to 2012 · $170,534 awarded in 2012Same name and institution; not confirmed by an ID
- Neurogenesis, Inflammation and Irradiation InjuryF30NS046967 · NINDS · STANFORD UNIVERSITY · fiscal years 2003 · $46,206 awarded in 2003Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumorsUM1CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Ira J Dunkel, Arzu Onar-Thomas · fiscal years 2014 to 2026Named on NCT04295759, NCT02717455
Most cited trial papers
Clinical-trial papers with this author name in glioma, ranked by citations from NIH iCite, fetched 2026-11-12 11:52 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed